Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ
Zmień bibliotekę

Wyszukujesz frazę ""PATIENT selection"" wg kryterium: Temat


Tytuł :
Defining in Detail and Evaluating Reliability of DSM-5 Criteria for Autism Spectrum Disorder (ASD) Among Children.
Autorzy :
Rice CE; Emory University, Atlanta, GA, USA. .; Centers for Disease Control and Prevention, Atlanta, GA, USA. .
Carpenter LA; Medical University of South Carolina, Charleston, SC, USA.
Morrier MJ; Emory University, Atlanta, GA, USA.
Lord C; University of California Los Angeles, Los Angeles, CA, USA.
DiRienzo M; Centers for Disease Control and Prevention, Atlanta, GA, USA.
Boan A; Medical University of South Carolina, Charleston, SC, USA.
Skowyra C; Washington University in St. Louis, St. Louis, MO, USA.
Fusco A; Rutgers New Jersey Medical School, Newark, NJ, USA.
Baio J; Centers for Disease Control and Prevention, Atlanta, GA, USA.
Esler A; University of Minnesota, Minneapolis, MN, USA.
Zahorodny W; Rutgers New Jersey Medical School, Newark, NJ, USA.
Hobson N; Independent Consultant, Keller, TX, USA.
Mars A; Hunterdon Healthcare System, Flemington, NJ, USA.
Thurm A; National Institute of Mental Health, Bethesda, MD, USA.
Bishop S; University of California San Francisco, San Francisco, CA, USA.
Wiggins LD; Centers for Disease Control and Prevention, Atlanta, GA, USA.
Pokaż więcej
Źródło :
Journal of autism and developmental disorders [J Autism Dev Disord] 2022 Dec; Vol. 52 (12), pp. 5308-5320. Date of Electronic Publication: 2022 Jan 04.
Typ publikacji :
Journal Article
MeSH Terms :
Autism Spectrum Disorder*/diagnosis
Autism Spectrum Disorder*/epidemiology
Diagnostic and Statistical Manual of Mental Disorders*
Patient Selection*
Child ; Humans ; Population Surveillance ; Prevalence ; Reproducibility of Results
Czasopismo naukowe
Tytuł :
Clinical Trial Enrollment, Ineligibility, and Reasons for Decline in Older vs Younger Patients With Cancer in the National Cancer Institute Community Oncology Research Program.
Autorzy :
Sedrak MS; Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, California.
Ji J; Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, California.
Tiwari A; Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, California.
Mohile SG; Department of Medicine, University of Rochester, Rochester, New York.
Dale W; Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, California.
Le-Rademacher JG; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota.
Pokaż więcej
Źródło :
JAMA network open [JAMA Netw Open] 2022 Oct 03; Vol. 5 (10), pp. e2235714. Date of Electronic Publication: 2022 Oct 03.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Clinical Trials as Topic*
Neoplasms*/therapy
Patient Selection*
Adult ; Aged ; Humans ; National Cancer Institute (U.S.) ; United States/epidemiology
Czasopismo naukowe
Tytuł :
Cancer Clinical Trial Enrollment in Older vs Younger Adults.
Autorzy :
Huang LW; Division of Hematology/Oncology, Department of Medicine, San Francisco Veterans Affairs Medical Center, San Francisco, California.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco.
Wang S; Division of Hematology/Oncology, Department of Medicine, San Francisco Veterans Affairs Medical Center, San Francisco, California.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco.
Pokaż więcej
Źródło :
JAMA network open [JAMA Netw Open] 2022 Oct 03; Vol. 5 (10), pp. e2235718. Date of Electronic Publication: 2022 Oct 03.
Typ publikacji :
Journal Article; Comment
MeSH Terms :
Clinical Trials as Topic*
Neoplasms*/therapy
Patient Selection*
Adult ; Aged ; Humans
Czasopismo naukowe
Tytuł :
A scoping review on patient heterogeneity in economic evaluations of precision medicine based on basket trials.
Autorzy :
Nosrati M; Department of Pharmacoeconomics and pharmaceutical administration, Faculty of Pharmacy, Tehran university of medical sciences, Tehran, Iran.
Nikfar S; Department of Pharmacoeconomics and pharmaceutical administration, Faculty of Pharmacy, Tehran university of medical sciences, Tehran, Iran.; Personalized Medicine Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran university of medical sciences, Tehran, Iran.
Hasanzad M; Personalized Medicine Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran university of medical sciences, Tehran, Iran.; Medical Genomics Research Center, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
Pokaż więcej
Źródło :
Expert review of pharmacoeconomics & outcomes research [Expert Rev Pharmacoecon Outcomes Res] 2022 Oct; Vol. 22 (7), pp. 1061-1070. Date of Electronic Publication: 2022 Aug 19.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Clinical Trials as Topic*/economics
Clinical Trials as Topic*/methods
Clinical Trials as Topic*/statistics & numerical data
Economics, Pharmaceutical*
Patient Selection*
Precision Medicine*/economics
Precision Medicine*/methods
Precision Medicine*/statistics & numerical data
Humans ; Neoplasms/drug therapy ; Neoplasms/economics ; Practice Guidelines as Topic
Czasopismo naukowe
Tytuł :
Patient responses to passive enrollment into a large, pragmatic clinical trial: A qualitative content analysis.
Autorzy :
Rozema EJ; Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, CA, United States of America. Electronic address: .
Creekmur B; Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, CA, United States of America.
Musigdilok VV; Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, CA, United States of America.
Steltz J; Division of Pulmonary, Allergy and Critical Care, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, United States of America.
Gould MK; Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, CA, United States of America; Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CA, United States of America.
Slatore CG; Center to Improve Veteran Involvement in Care, VA Portland Health Care System, Portland, OR, United States of America; Division of Pulmonary & Critical Care Medicine, Department of Medicine, Oregon Health & Science University, Portland, OR, United States of America; Section of Pulmonary & Critical Care Medicine, VA Portland Health Care System, Portland, OR, United States of America.
Pokaż więcej
Źródło :
Contemporary clinical trials [Contemp Clin Trials] 2022 Oct; Vol. 121, pp. 106925. Date of Electronic Publication: 2022 Sep 13.
Typ publikacji :
Journal Article
MeSH Terms :
Patient Selection*
Pragmatic Clinical Trials as Topic*
Humans ; Qualitative Research ; Surveys and Questionnaires
Czasopismo naukowe
Tytuł :
Factors impacting participation in research during the COVID-19 pandemic: results from a survey of patients in the ophthalmology outpatient department.
Autorzy :
Abdulhussein D; Imperial College Ophthalmic Research Group (ICORG), Imperial College London, Exhibition Road, London, NW1 5QH, UK. .; Imperial College London, Exhibition Road, London, SW7 2AZ, UK. .
Yap TE; Imperial College Ophthalmic Research Group (ICORG), Imperial College London, Exhibition Road, London, NW1 5QH, UK.
Manzar H; Imperial College Ophthalmic Research Group (ICORG), Imperial College London, Exhibition Road, London, NW1 5QH, UK.
Miodragovic S; Imperial College Ophthalmic Research Group (ICORG), Imperial College London, Exhibition Road, London, NW1 5QH, UK.
Cordeiro F; Imperial College Ophthalmic Research Group (ICORG), Imperial College London, Exhibition Road, London, NW1 5QH, UK.; Glaucoma & Retinal Neurodegeneration Research Group, Institute of Ophthalmology, University College London, London, EC1V 9EL, UK.
Pokaż więcej
Źródło :
Trials [Trials] 2022 Sep 30; Vol. 23 (1), pp. 823. Date of Electronic Publication: 2022 Sep 30.
Typ publikacji :
Journal Article
MeSH Terms :
COVID-19*
Ophthalmology*
Patient Participation*
Patient Selection*
Clinical Trials as Topic ; Humans ; Outpatients ; Pandemics ; Surveys and Questionnaires
Czasopismo naukowe
Tytuł :
Who to Enroll in Parkinson Disease Prevention Trials? The Case for Genetically At-Risk Cohorts.
Autorzy :
Niotis K; From the Department of Neurology (K.N., R.S.-P.), Mount Sinai Beth Israel Medical Center; Department of Neurology (K.N., R.S.-P.), Icahn School of Medicine at Mount Sinai, New York; and Duke Center for Neurodegeneration Research (A.B.W.), Departments of Pharmacology and Cancer Biology, Neurology, and Neurobiology, Duke University, Durham, NC.
West AB; From the Department of Neurology (K.N., R.S.-P.), Mount Sinai Beth Israel Medical Center; Department of Neurology (K.N., R.S.-P.), Icahn School of Medicine at Mount Sinai, New York; and Duke Center for Neurodegeneration Research (A.B.W.), Departments of Pharmacology and Cancer Biology, Neurology, and Neurobiology, Duke University, Durham, NC.
Saunders-Pullman R; From the Department of Neurology (K.N., R.S.-P.), Mount Sinai Beth Israel Medical Center; Department of Neurology (K.N., R.S.-P.), Icahn School of Medicine at Mount Sinai, New York; and Duke Center for Neurodegeneration Research (A.B.W.), Departments of Pharmacology and Cancer Biology, Neurology, and Neurobiology, Duke University, Durham, NC. .
Pokaż więcej
Źródło :
Neurology [Neurology] 2022 Aug 16; Vol. 99 (7 Suppl 1), pp. 10-18.
Typ publikacji :
Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms :
Parkinson Disease*/complications
Parkinson Disease*/genetics
Parkinson Disease*/prevention & control
Patient Selection*
Biomarkers ; Glucosylceramidase/genetics ; Heterozygote ; Humans ; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2/genetics ; Research Design
Czasopismo naukowe
Tytuł :
The Leaf Clinical Trials Corpus: a new resource for query generation from clinical trial eligibility criteria.
Autorzy :
Dobbins NJ; Department of Biomedical Informatics & Medical Education, University of Washington, Seattle, WA, USA. .
Mullen T; Khoury College of Computer Science, Northeastern University, Seattle, WA, USA.
Uzuner Ö; Department of Information Sciences and Technology, George Mason University, Fairfax, VA, USA.
Yetisgen M; Department of Biomedical Informatics & Medical Education, University of Washington, Seattle, WA, USA.
Pokaż więcej
Źródło :
Scientific data [Sci Data] 2022 Aug 11; Vol. 9 (1), pp. 490. Date of Electronic Publication: 2022 Aug 11.
Typ publikacji :
Dataset; Journal Article
MeSH Terms :
Clinical Trials as Topic*/standards
Natural Language Processing*
Patient Selection*
Databases, Factual ; Humans ; Information Storage and Retrieval
Czasopismo naukowe
Tytuł :
A population study of clinical trial accrual for women and minorities in neuro-oncology following the NIH Revitalization Act.
Autorzy :
Reihl SJ; University of California, San Francisco, Department of Neurosurgery, San Francisco, California,USA.
Patil N; Central Brain Tumor Registry of the United States (CBTRUS), Hinsdale, Illinois, USA.; University Health System, Research and Education Institute, Cleveland, Ohio, USA.; University Hospitals Health System, Research Health Analytics and Informatics, Cleveland, Ohio, USA.
Morshed RA; University of California, San Francisco, Department of Neurosurgery, San Francisco, California,USA.
Mehari M; University of California, San Francisco, Department of Neurosurgery, San Francisco, California,USA.
Aabedi A; University of California, San Francisco, Department of Neurosurgery, San Francisco, California,USA.
Chukwueke UN; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Department of Neurology, Harvard Medical School, Boston, Massachusetts, USA.
Porter AB; Mayo Clinic, Division of Neuro-Oncology, Department of Neurology, Phoenix, Arizona, USA.
Fontil V; University of California San Francisco, Division of General Internal Medicine, San Francisco, California, USA.; University of California San Francisco, Center for Vulnerable Populations, Zuckerberg San Francisco General Hospital, San Francisco, California, USA.
Cioffi G; Division of Cancer Epidemiology and Genetics, Trans-Divisional Research Program, National Cancer Institute, Bethesda, Maryland,USA.; Central Brain Tumor Registry of the United States (CBTRUS), Hinsdale, Illinois, USA.
Waite K; Division of Cancer Epidemiology and Genetics, Trans-Divisional Research Program, National Cancer Institute, Bethesda, Maryland,USA.; Central Brain Tumor Registry of the United States (CBTRUS), Hinsdale, Illinois, USA.
Kruchko C; Central Brain Tumor Registry of the United States (CBTRUS), Hinsdale, Illinois, USA.
Ostrom Q; Central Brain Tumor Registry of the United States (CBTRUS), Hinsdale, Illinois, USA.; Department of Neurosurgery, Duke University School of Medicine, Durham, North Carolina, USA.; The Preston Robert Tisch Brain Tumor Center, Duke University School of Medicine, Durham, North Carolina, USA.; Duke Cancer Institute, Duke University Medical Center, Durham, North Carolina, USA.
Barnholtz-Sloan J; Central Brain Tumor Registry of the United States (CBTRUS), Hinsdale, Illinois, USA.; Center for Biomedical Informatics and Information Technology, National Cancer Institute, Bethesda, Maryland,USA.
Hervey-Jumper SL; University of California, San Francisco, Department of Neurosurgery, San Francisco, California,USA.
Pokaż więcej
Źródło :
Neuro-oncology [Neuro Oncol] 2022 Aug 01; Vol. 24 (8), pp. 1341-1349.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Research Support, N.I.H., Extramural
MeSH Terms :
Clinical Trials as Topic*
Neoplasms*/therapy
Patient Selection*
Female ; Humans ; Male ; Minority Groups ; National Institutes of Health (U.S.) ; Research Design ; United States
Czasopismo naukowe
Tytuł :
Clinical Trials in Hepatopancreatobiliary Surgery: Assessing Trial Characteristics, Early Discontinuation, Result Reporting, and Publication.
Autorzy :
Khachfe HH; Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, USA. .; Division of GI Surgical Oncology, UPMC Pancreatic Cancer Center, University of Pittsburgh Medical Center, UPMC Cancer Pavilion, Pittsburgh, PA, USA. .; Division of GI Surgical Oncology, Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, USA. .
Habib JR; Department of Surgery, University of Maryland, Baltimore, MD, USA.
Nassour I; Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.; Division of GI Surgical Oncology, UPMC Pancreatic Cancer Center, University of Pittsburgh Medical Center, UPMC Cancer Pavilion, Pittsburgh, PA, USA.
Baydoun HA; Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Ghabi EM; Department of Surgery, Johns Hopkins University, Baltimore, MD, USA.
Chahrour MA; Department of Surgery, Henry Ford Health System, Detroit, MI, USA.
Hallal AH; Department of Surgery, Sheikh Shakhbout Medical City, Abu Dhabi, United Arab Emirates.
Jamali FR; Department of Surgery, Sheikh Shakhbout Medical City, Abu Dhabi, United Arab Emirates.
Pokaż więcej
Źródło :
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract [J Gastrointest Surg] 2022 Aug; Vol. 26 (8), pp. 1628-1636. Date of Electronic Publication: 2022 Jun 17.
Typ publikacji :
Journal Article
MeSH Terms :
Patient Selection*
Humans
Czasopismo naukowe
Tytuł :
Balancing the Therapeutic Ratio in DLBCL Requires Appropriate, Individualized Patient Selection Rather Than Broad Elimination of Radiation Therapy.
Autorzy :
Campbell BA; Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia; Department of Clinical Pathology, University of Melbourne, Parkville, Victoria, Australia. Electronic address: .
Bakst RL; Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, New York.
Milgrom SA; Department of Radiation Oncology, University of Colorado, Aurora, Colorado.
Seymour JF; The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia; Department of Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Victoria, Australia.
Pokaż więcej
Źródło :
International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2022 Jul 01; Vol. 113 (3), pp. 479-488.
Typ publikacji :
Editorial; Comment
MeSH Terms :
Patient Selection*
Humans
Opinia redakcyjna
Tytuł :
Increasing Racial and Ethnic Diversity in Cancer Clinical Trials: An American Society of Clinical Oncology and Association of Community Cancer Centers Joint Research Statement.
Autorzy :
Oyer RA; Penn Medicine Lancaster General Health Ann B Barshinger Cancer Institute, Lancaster, PA.
Hurley P; American Society of Clinical Oncology, Alexandria, VA.
Boehmer L; Association of Community Cancer Centers, Rockville, MD.
Bruinooge SS; American Society of Clinical Oncology, Alexandria, VA.
Levit K; American Society of Clinical Oncology, Alexandria, VA.
Barrett N; Duke Clinical and Translational Science Institute, Raleigh, NC.
Benson A; Northwestern University, Evanston, IL.
Bernick LA; Sutter Cancer Research Consortium, Novato, CA.
Byatt L; University of New Mexico Comprehensive Cancer Center, Albuquerque, NM.
Charlot M; University of North Carolina Chapel Hill, Chapel Hill, NC.
Crews J; University of Washington, Seattle, WA.
DeLeon K; American Cancer Society Cancer Action Network, Washington, DC.
Fashoyin-Aje L; US Food and Drug Administration Oncology Center of Excellence, Silver Spring, MD.
Garrett-Mayer E; American Society of Clinical Oncology, Alexandria, VA.
Gralow JR; American Society of Clinical Oncology, Alexandria, VA.
Green S; American Society of Clinical Oncology, Alexandria, VA.
Guerra CE; University of Pennsylvania Raymond and Ruth Perelman School of Medicine, Philadelphia, PA.
Hamroun L; ChristianaCare Oncology Patient Advocates for Clinical Trials, Newark, DE.
Hardy CM; University of Alabama at Birmingham O'Neal Comprehensive Cancer Center, Birmingham, AL.
Hempstead B; Cierra Sisters, Renton, WA.
Jeames S; Huston-Tillotson University, Austin, TX.
Mann M; Patient Advocate, Jonesboro, GA.
Matin K; Virginia Commonwealth University, Richmond, VA.
McCaskill-Stevens W; National Cancer Institute, Bethesda, MD.
Merrill J; American Society of Clinical Oncology, Alexandria, VA.
Nowakowski GS; Mayo Clinic, Rochester, MN.
Patel MI; Stanford Health Care, Stanford, CA.
Pressman A; PRECISIONheor, Los Angeles, CA.
Ramirez AG; University of Texas Health San Antonio, San Antonio, TX.
Segura J; Patient Advocate, East Chicago, IN.
Segarra-Vasquez B; University of Puerto Rico, San Juan, Puerto Rico.
Hanley Williams J; American Society of Clinical Oncology, Alexandria, VA.
Williams JE Jr; Jim Williams and Associates, Camp Hill, PA.
Winkfield KM; Meharry-Vanderbilt Alliance, Nashville, TN.
Yang ES; University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL.
Zwicker V; Association of Community Cancer Centers, Rockville, MD.
Pierce LJ; University of Michigan, Ann Arbor, MI.
Pokaż więcej
Źródło :
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2022 Jul 01; Vol. 40 (19), pp. 2163-2171. Date of Electronic Publication: 2022 May 19.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Clinical Trials as Topic*
Ethnicity*
Neoplasms*/therapy
Patient Selection*
Humans ; Medical Oncology ; Minority Groups ; Racial Groups ; United States
Czasopismo naukowe
Tytuł :
Underserved groups remain underserved as eligibility criteria routinely exclude them from breast cancer trials.
Autorzy :
Moloney C; TRAMS (Trials Research and Methodologies Unit), Trial Forge, HRB Clinical Research Facility, University College, Cork, Ireland.
Shiely F; TRAMS (Trials Research and Methodologies Unit), Trial Forge, HRB Clinical Research Facility, University College, Cork, Ireland; School of Public Health, University College, Cork, Ireland. Electronic address: .
Pokaż więcej
Źródło :
Journal of clinical epidemiology [J Clin Epidemiol] 2022 Jul; Vol. 147, pp. 132-141. Date of Electronic Publication: 2022 Mar 25.
Typ publikacji :
Journal Article
MeSH Terms :
Breast Neoplasms*/therapy
Medically Underserved Area*
Patient Selection*
Healthcare Disparities*
Female ; Humans ; Clinical Trials as Topic ; Randomized Controlled Trials as Topic
Czasopismo naukowe
Tytuł :
The Imperative for Diversity and Inclusion in Clinical Trials and Health Research Participation.
Autorzy :
Bibbins-Domingo K; Department of Epidemiology and Biostatistics, University of California, San Francisco.
Helman A; National Academies of Sciences, Engineering, and Medicine, Washington, DC.
Dzau VJ; National Academy of Medicine, Washington, DC.
Pokaż więcej
Źródło :
JAMA [JAMA] 2022 Jun 21; Vol. 327 (23), pp. 2283-2284.
Typ publikacji :
Journal Article
MeSH Terms :
Biomedical Research*/standards
Clinical Trials as Topic*/standards
Cultural Diversity*
Patient Selection*
Prejudice*
Social Inclusion*
Czasopismo naukowe
Tytuł :
Selecting the best candidates for non-surgical management of localized renal masses: the Occam's razor.
Autorzy :
Campi R; Unit of Urological Robotic Surgery and Renal Transplantation, Department of Experimental and Clinical Medicine, Careggi Hospital, University of Florence, Florence, Italy - .
Muselaers S; Department of Urology, Radboud University Medical Center, Nijmegen, the Netherlands.
Bertolo R; Department of Urology, San Carlo Di Nancy Hospital, Rome, Italy.
Erdem S; Division of Urologic Oncology, Department of Urology, Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Marchioni M; Department of Medical, Oral and Biotechnological Sciences, Laboratory of Biostatistics, G. D'Annunzio University, Chieti, Italy.; Department of Urology, SS. Annunziata Hospital, G. D'Annunzio University, Chieti, Italy.
Ingels A; Department of Urology, Henri Mondor University Hospital, APHP, Créteil, France.; Biomaps, UMR1281, INSERM, CNRS, CEA, University of Paris Saclay, Villejuif, France.
Kara Ö; School of Medicine, Department of Urology, Kocaeli University, Kocaeli, Turkey.
Carbonara U; Unit of Andrology and Kidney Transplantation, Department of Emergency and Organ Transplantation-Urology, University of Bari, Bari, Italy.
Pecoraro A; Division of Urology, Pederzoli Hospital, Peschiera del Garda, Verona, Italy.
Pavan N; Department of Medical, Surgical and Health Science, Clinic of Urology, University of Trieste, Trieste, Italy.
Marandino L; Division of Experimental Oncology, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Roussel E; Department of Urology, Leuven University Hospital, Leuven, Belgium.
Amparore D; School of Medicine, Division of Urology, Department of Oncology, San Luigi Gonzaga Hospital, University of Turin, Orbassano, Turin, Italy.
Pokaż więcej
Corporate Authors :
EAU Young Academic Urologists (YAU) Renal Cancer Working Group
Źródło :
Minerva urology and nephrology [Minerva Urol Nephrol] 2022 Jun; Vol. 74 (3), pp. 368-371.
Typ publikacji :
Journal Article; Comment
MeSH Terms :
Kidney Neoplasms*/therapy
Patient Selection*
Humans
Czasopismo naukowe
Tytuł :
Diverse Recruitment Strategies Are Needed to Reduce Digital Divide: Results from a Workshop Addressing Digital Divide and Effects of Pandemic Restrictions.
Autorzy :
Bradway M; Norwegian Centre for E-health Research, University Hospital, Tromsø, Norway.
Årsand E; Department of Computer Science, The Arctic University of Norway, Tromsø, Norway.; Norwegian Centre for E-health Research, University Hospital, Tromsø, Norway.
Pokaż więcej
Źródło :
Studies in health technology and informatics [Stud Health Technol Inform] 2022 May 25; Vol. 294, pp. 811-812.
Typ publikacji :
Journal Article
MeSH Terms :
COVID-19*
Digital Divide*
Pandemics*/prevention & control
Patient Selection*
SARS-CoV-2*
Research Design/*standards
Community-Based Participatory Research/statistics & numerical data ; Humans ; Peer Group
Czasopismo naukowe
Tytuł :
Success and failure factors of patient recruitment for industry-sponsored clinical trials and the role of the electronic health records-a qualitative interview study in the Nordic countries.
Autorzy :
Laaksonen N; Institute of Biomedicine, University of Turku, Turku, Finland. .
Bengtström M; Pharma Industry Finland, Helsinki, Finland.; Pharmaceutical Sciences Laboratory, Åbo Akademi University, Turku, Finland.
Axelin A; Department of Nursing Science, University of Turku, Turku, Finland.
Blomster J; Department of Cardiology, University of Turku and Turku University Hospital, Turku, Finland.
Scheinin M; Institute of Biomedicine, University of Turku, Turku, Finland.; Clinical Pharmacology Unit, Turku University Hospital, Turku, Finland.
Huupponen R; Institute of Biomedicine, University of Turku, Turku, Finland.; Clinical Pharmacology Unit, Turku University Hospital, Turku, Finland.
Pokaż więcej
Źródło :
Trials [Trials] 2022 May 12; Vol. 23 (1), pp. 385. Date of Electronic Publication: 2022 May 12.
Typ publikacji :
Journal Article
MeSH Terms :
Clinical Trials as Topic*
Electronic Health Records*
Patient Selection*
Humans ; Qualitative Research ; Research Personnel ; Scandinavian and Nordic Countries
Czasopismo naukowe
Tytuł :
Reply: Patient selection is both the problem and the solution.
Autorzy :
Bichell D; Department of Cardiac Surgery, Monroe Carell, Jr, Children's Hospital, Vanderbilt University Medical Center, Nashville, Tenn.
Pokaż więcej
Źródło :
The Journal of thoracic and cardiovascular surgery [J Thorac Cardiovasc Surg] 2022 May; Vol. 163 (5), pp. e336. Date of Electronic Publication: 2021 Feb 17.
Typ publikacji :
Letter
MeSH Terms :
Patient Selection*
Humans
Opinia redakcyjna

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies